Literature DB >> 11384190

Kinetic and titration methods for determination of active site contents of enzyme and catalytic antibody preparations.

K Brocklehurst1, M Resmini, C M Topham.   

Abstract

Kinetic characterization of enzymes and analogous catalysts such as catalytic antibodies requires knowledge of the molarity of functional sites. Various stoichiometric titration methods are available for the determination of active-site concentrations of some enzymes and these are exemplified in the second part of this article. Most of these are not general in that they require the existence of certain types of either intermediate or active-site residues that are susceptible to specific covalent modification. Thus they are not readily applicable to many enzymes and they are rarely available currently for titration of catalytic antibody active sites. In the first part of the article we discuss a general kinetic method for the investigation of active-site availability in preparations of macromolecular catalysts. The method involves steady-state kinetics to provide Vmax and Km and single-turnover first-order kinetics using excess of catalyst over substrate to provide the analogous parameters k(obs)lim and K(m)app. The active-site contents of preparations that contain only active catalyst (Ea) and inert material (Ei) may be calculated as [Ea](T) = Vmax)/k(obs)lim. This is true even if nonproductive binding to E(a) occurs. For polyclonal catalytic antibody preparations, which may contain binding but noncatalytic material (Eb) in addition to Ea and Ei, the significance of Vmax/k(obs)lim is more complex but provides an upper limit to E(a). This can be refined by consideration of the relative values of Km and the equilibrium dissociation constant of EbS. Analysis of the Ea, Eb, Ei system requires the separate determination of Ei. For catalytic antibodies this may be achieved by analytical affinity chromatography using an immobilized hapten or hapten analog and an ELISA procedure to ensure the clean separation of Ei from the Ea + Eb mixture. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11384190     DOI: 10.1006/meth.2001.1176

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  3 in total

1.  Evidence for 'lock and key' character in an anti-phosphonate hydrolytic antibody catalytic site augmented by non-reaction centre recognition: variation in substrate selectivity between an anti-phosphonate antibody, an anti-phosphate antibody and two hydrolytic enzymes.

Authors:  Sanjiv Sonkaria; Guillaume Boucher; José Flórez-Olvarez; Bilal Said; Syeed Hussain; Elizabeth L Ostler; Sheraz Gul; Emrys W Thomas; Marina Resmini; Gerard Gallacher; Keith Brocklehurst
Journal:  Biochem J       Date:  2004-07-01       Impact factor: 3.857

2.  Improvement in hydrolytic antibody activity by change in haptenic structure from phosphate to phosphonate with retention of a common leaving-group determinant: evidence for the 'flexibility' hypothesis.

Authors:  Sheraz Gul; Sanjiv Sonkaria; Surapong Pinitglang; José Florez-Alvarez; Syeed Hussain; Emrys W Thomas; Elizabeth L Ostler; Gerard Gallacher; Marina Resmini; Keith Brocklehurst
Journal:  Biochem J       Date:  2003-12-15       Impact factor: 3.857

3.  Evidence that the mechanism of antibody-catalysed hydrolysis of arylcarbamates can be determined by the structure of the immunogen used to elicit the catalytic antibody.

Authors:  Guillaume Boucher; Bilal Said; Elizabeth L Ostler; Marina Resmini; Keith Brocklehurst; Gerard Gallacher
Journal:  Biochem J       Date:  2007-02-01       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.